Bank Of Montreal Moderna, Inc. Call Options Transaction History

Bank Of Montreal

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 02, 2023	SELL	$118.5 - $160.53 $1.14 Million - $1.54 Million	-9,600 Reduced 31.07%	21,300 $2.59 Million
Q4 2022 Feb 01, 2023	SELL	$118.38 - $210.04 $887,850 - $1.58 Million	-7,500 Reduced 19.53%	30,900 $5.55 Million
Q3 2022 Nov 10, 2022	BUY	$118.07 - $194.18 $2.36 Million - $3.88 Million	20,000 Added 108.7%	38,400 $5.46 Million
Q2 2022 Aug 11, 2022	SELL	$117.13 - $176.59 $2.78 Million - $4.19 Million	-23,700 Reduced 56.29%	18,400 $2.68 Million
Q1 2022 May 12, 2022	BUY	$126.46 - $235.05 $3 Million - $5.57 Million	23,700 Added 128.8%	42,100 $7.62 Million
Q4 2021 Feb 11, 2022	BUY	$225.82 - $368.51 $4.16 Million - $6.78 Million	18,400 New	18,400 $4.63 Million

953

240M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.